Anthem Biosciences Limited (NSE:ANTHEM)

India · Delayed Price · Currency is INR

771.70

+10.20 (1.34%)

At close: Oct 1, 2025

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Development & Manufacturing	8.98B	Log In	Log In
Development & Manufacturing Growth	41.36%	Log In	Log In
Speciality Ingredients	3.36B	Log In	Log In
Speciality Ingredients Growth	35.11%	Log In	Log In
Research & Development Services	1.86B	Log In	Log In
Research & Development Services Growth	7.18%	Log In	Log In

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Year Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Europe	6.13B	Log In	Log In
Europe Growth	100.13%	Log In	Log In
North America (USA)	4.29B	Log In	Log In
North America (USA) Growth	-14.17%	Log In	Log In
India	3.09B	Log In	Log In
India Growth	45.12%	Log In	Log In
Rest of Asia & Others	681.44M	Log In	Log In
Rest of Asia & Others Growth	81.74%	Log In	Log In